ArticleBrain pathology (Zurich, Switzerland)2026
Tau-targeting active immunotherapy slows progression and reduces pathology in mouse models of tauopathy.
Christopher M Brown et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it